ストックスクリーナーアプリを入手
5.72
1.96%
0.11
アフターアワーズ：
5.57
-0.15
-2.62%
前日終値:
$5.61
開ける：
$5.7
24時間の取引高:
40,381
Relative Volume:
0.04
時価総額：
$85.70M
収益：
$41.94M
当期純損益:
$-7.40M
株価収益率:
-11.59
EPS:
-0.4935
ネットキャッシュフロー:
$1.29M
1週間 パフォーマンス:
+0.88%
1か月 パフォーマンス:
+11.72%
6か月 パフォーマンス:
+30.59%
1年 パフォーマンス:
+6.72%
1日の値動き範囲:
$5.4633
$5.75
1週間の範囲:
$5.435
$5.82
52週間の値動き範囲:
$1.85
$6.61
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
名前
Cumberland Pharmaceuticals Inc
セクター
電話
615-255-0068
住所
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
5.72 | 85.70M | 41.94M | -7.40M | 1.29M | -0.4935 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2012-11-12 | 繰り返されました | UBS | Neutral |
| 2011-02-01 | 繰り返されました | UBS | Neutral |
| 2010-12-16 | ダウングレード | UBS | Buy → Neutral |
| 2010-08-17 | ダウングレード | Jefferies | Buy → Hold |
| 2010-08-17 | 繰り返されました | Morgan Joseph | Buy |
| 2010-08-17 | 繰り返されました | UBS | Buy |
| 2010-05-14 | 繰り返されました | Morgan Joseph | Buy |
すべてを表示
Cumberland Pharmaceuticals Inc (CPIX) 最新ニュース
Cumberland Pharmaceuticals Inc (CPIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
RedHill Biopharma raises $6M now, with $13.4M more tied to warrants - Stock Titan
Cumberland Pharmaceuticals Inc - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cumberland Pharmaceuticals Inc (CPIX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CPIX News | CUMBERLAND PHARMACEUTICALS (NASDAQ:CPIX) - ChartMill
CPIX Q1 2026 Earnings: Narrowing Losses Amidst Operational UncertaintyEPS Surprise History - newsline.com
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Brown Martin S JR - Moomoo
RedHill moves to enforce $10.9M New York judgment on Kukbo in Korea - Stock Titan
Cumberland Pharmaceuticals (CPIX) Extends Decline Amid Low Volume PressurePrice Target - newsline.com
Cumberland shares soar on $100M deal announcement - Nashville Post
Cumberland reports positive phase 2a cancer trial results - Investing.com UK
Cumberland Pharmaceuticals And Vanderbilt Announce Phase 2A Trial Data For ifetroban In High-Risk Solid Tumors - TradingView
Early trial hints at drug to cut risk of cancer returning after treatment - Stock Titan
Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis - Yahoo Finance
Cumberland Pharmaceuticals (CPIX) Gains Momentum: Up 2.84% on Normal Trading ActivityIV Percentile - The Legal Advocate
Cumberland Pharma Stock Rises After China Antibiotic Launch — Why Investors Are Watching - Bez Kabli
Cumberland Pharmaceuticals Hits New 52-Week High of $6.51 - MarketsMojo
CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA - Citizen Tribune
Number of shareholders of Cumberland Pharmaceuticals Inc. – NASDAQ:CPIX - TradingView
The Zacks Analyst Blog Highlights Alphabet, Apple, Micron Technology, Cumberland Pharmaceuticals and AmeriServ Financial - Yahoo Finance
New MRSA-fighting antibiotic Vibativ now available to patients in China - Stock Titan
CPIX Q1 2026 Earnings: Net Loss Reported, Shares Edge HigherGuidance Revision Trend - The Legal Advocate
CPIX Q1 2026 Earnings: Narrowing Losses and Strategic Progress Amidst Revenue ChallengesDividend Increase Stocks - The Legal Advocate
Cumberland Pharmaceuticals(CPIX) Stock Options Chain | Quotes & News - Moomoo
$Cumberland Pharmaceuticals (CPIX.US)$ Soaring!!!! - Moomoo
Cumberland Pharmaceuticals (NASDAQ: CPIX) to divest marketed brands to Apotex for $100M - Stock Titan
- The Legal Advocate
CPIX Q1 2026 Earnings: Loss Per Share of $0.13 as Stock Rebounds 6.5%Guidance Upgrade Report - newsline.com
Cumberland Pharmaceuticals jumps on $100M Apotex transaction - MSN
Cumberland Pharmaceuticals (CPIX) to sell U.S. brands to Apotex for $100M - Stock Titan
Cumberland outlines $100M Apotex deal while shifting to development-focused strategy - MSN
Cumberland Pharmaceuticals Inc. Q1 2026 Financial Results: Revenue, Expenses, and Company Overview - Minichart
$100M Apotex deal to reshape Cumberland (CPIX) into development player - Stock Titan
MSN Money - MSN
What Cumberland (CPIX) does that creates lasting value (Slight Dip) 2026-05-08Supply Zone - newsline.com
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2026 Earnings Call Transcript - Insider Monkey
Cumberland Pharmaceuticals Divests US Portfolio to Apotex for $100 Million - HarianBasis.co
Cumberland Pharmaceuticals Pivots After Transformational Apotex Deal - TipRanks
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan - Yahoo Finance
Cumberland Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Cumberland: Q1 Earnings Snapshot - theheraldreview.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Issues Earnings Results - MarketBeat
Cumberland Pharmaceuticals Sells FDA-Approved Brands for $100 Million to Apotex, Reports Q1 2026 Financial Results and Focuses on Orphan Drug Pipeline 1 - Minichart
Cumberland Pharmaceuticals Q1 Earnings Call Highlights - MarketBeat
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln - TradingView
Cumberland Pharmaceuticals Inc. (CPIX) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
CPIX: $100M Apotex deal and FDA approvals mark a strategic pivot to pipeline innovation - TradingView
Earnings call transcript: Cumberland Pharmaceuticals Q1 2026 shows mixed results - Investing.com
Cumberland Pharmaceuticals Inc (CPIX) 財務データ
収益
当期純利益
現金流量
EPS
11.23%
0.45%
大文字化:
|
ボリューム (24 時間):